Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Methotrexate-associated osteonecrosis of the jaw: A report of two cases.

Henien M, Carey B, Hullah E, Sproat C, Patel V.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Dec;124(6):e283-e287. doi: 10.1016/j.oooo.2017.09.005. Epub 2017 Sep 21.

PMID:
29056286
2.

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.

J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24.

PMID:
25053572
3.

Radiology quiz case. Osteonecrosis of the jaw: aminobisphosphonate epidemic.

Junquera L, Gallego L, Villarreal P.

Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1229-31. doi: 10.1001/archotol.134.11.1229. No abstract available.

PMID:
19015457
4.

Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab.

Neuprez A, Coste S, Rompen E, Crielaard JM, Reginster JY.

Osteoporos Int. 2014 Jan;25(1):393-5. doi: 10.1007/s00198-013-2437-z. Epub 2013 Jul 9.

5.

Bisphosphonate-related osteonecrosis of the jaws: a report of three cases demonstrating variability in outcomes and morbidity.

Kumar V, Pass B, Guttenberg SA, Ludlow J, Emery RW, Tyndall DA, Padilla RJ.

J Am Dent Assoc. 2007 May;138(5):602-9.

PMID:
17473037
6.

Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.

Aghaloo TL, Tetradis S.

J Oral Maxillofac Surg. 2017 Jan;75(1):129-142. doi: 10.1016/j.joms.2016.07.019. Epub 2016 Jul 30.

7.

Medication-related osteonecrosis of the jaw associated with aflibercept.

Zarringhalam P, Brizman E, Shakib K.

Br J Oral Maxillofac Surg. 2017 Apr;55(3):314-315. doi: 10.1016/j.bjoms.2016.11.315. Epub 2016 Dec 4. No abstract available.

PMID:
27923511
8.

Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab.

Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS.

Oral Maxillofac Surg. 2013 Dec;17(4):303-6. doi: 10.1007/s10006-012-0379-9. Epub 2012 Dec 16.

PMID:
23242941
9.

Spontaneous bone formation after mandible segmental resection in "krokodil" drug-related jaw osteonecrosis patient: case report.

Hakobyan K, Poghosyan Y.

Oral Maxillofac Surg. 2017 Jun;21(2):267-270. doi: 10.1007/s10006-017-0613-6. Epub 2017 Mar 1.

PMID:
28251363
10.

Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

Treister NS, Friedland B, Woo SB.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):753-64. doi: 10.1016/j.tripleo.2009.12.005. Epub 2010 Mar 29.

PMID:
20303301
11.

Stage 0 osteonecrosis of the jaw in a patient on denosumab.

Aghaloo TL, Dry SM, Mallya S, Tetradis S.

J Oral Maxillofac Surg. 2014 Apr;72(4):702-16. doi: 10.1016/j.joms.2013.09.008. Epub 2014 Jan 4.

12.

Denosumab-related osteonecrosis of the jaw.

Diz P, López-Cedrún JL, Arenaz J, Scully C.

J Am Dent Assoc. 2012 Sep;143(9):981-4.

PMID:
22942143
13.

Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.

Furukawa S, Oobu K, Moriyama M, Kawano S, Sako S, Hayashida JN, Matsubara R, Ogata KI, Kiyoshima T, Nakamura S.

Intern Med. 2018 Feb 15;57(4):575-581. doi: 10.2169/internalmedicine.8946-17. Epub 2017 Dec 8. Review.

14.

Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis.

Torres SR, Chen CS, Leroux BG, Lee PP, Hollender LG, Schubert MM.

Dentomaxillofac Radiol. 2011 Dec;40(8):501-5. doi: 10.1259/dmfr/14636637.

15.

Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.

Bedogni A, Fedele S, Bedogni G, Scoletta M, Favia G, Colella G, Agrillo A, Bettini G, Di Fede O, Oteri G, Fusco V, Gabriele M, Ottolenghi L, Valsecchi S, Porter S, Petruzzi M, Arduino P, D'Amato S, Ungari C, Fung Polly PL, Saia G, Campisi G.

Br J Oral Maxillofac Surg. 2014 Sep;52(7):603-8. doi: 10.1016/j.bjoms.2014.04.009. Epub 2014 May 22.

16.

Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.

Wutzl A, Eisenmenger G, Hoffmann M, Czerny C, Moser D, Pietschmann P, Ewers R, Baumann A.

Wien Klin Wochenschr. 2006 Aug;118(15-16):473-8.

PMID:
16957978
17.

Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?

Klingelhöffer C, Klingelhöffer M, Müller S, Ettl T, Wahlmann U.

Dentomaxillofac Radiol. 2016;45(5):20160065. doi: 10.1259/dmfr.20160065. Epub 2016 May 23.

18.

Zoledronate-related osteonecrosis of the mandible.

Ho L, Quan V, Henderson R.

Clin Nucl Med. 2008 Jan;33(1):68-70.

PMID:
18097268
19.

Denosumab-associated osteonecrosis of the jaw--a case report.

Vyas S, Hameed S, Murugaraj V.

Dent Update. 2014 Jun;41(5):449-50.

PMID:
25073227
20.

The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.

Dodson TB.

Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9. Review.

PMID:
26362367

Supplemental Content

Support Center